Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("VANRENTERGHEM, Yves")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 116

  • Page / 5
Export

Selection :

  • and

Post-Transplant Diabetes Mellitus and Renal Function with Tacrolimus: A Decade of Use, a Decade of EvidenceVANRENTERGHEM, Yves.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, issn 0931-0509, 24 p., SUP6Conference Proceedings

Prevalence and management of anaemia in transplant patientsVANRENTERGHEM, Yves.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, issn 0931-0509, p. 47, SUP1Conference Paper

The art of immunosuppression: tailoring therapy for the future, Rome, Italy, August 2000VANRENTERGHEM, Yves.Transplantation proceedings. 2001, Vol 33, Num 3A, issn 0041-1345, 12 p., SUPConference Proceedings

Posttransplant Cardiovascular Risk: Impact on Long-Term Patient Survival, Proceedings of a CME-accredited meeting held in Chicago, Illinois, U.S.A., March 13, 2000VANRENTERGHEM, Yves.Transplantation. 2001, Vol 72, Num 6, issn 0041-1337, 24 p., SUPConference Proceedings

Improving long-term renal transplant outcomes with tacrolimus: speculation vs evidenceFIRST, M. Roy.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, pp vi17-vi22, issn 0931-0509, SUP6Conference Paper

General considerations of immunosuppressive therapies-efficacy versus toxicityHELDERMAN, J. H.Transplantation proceedings. 2001, Vol 33, Num 3A, pp S2-S3, issn 0041-1345, SUPConference Paper

Anaemia after renal transplantationVANRENTERGHEM, Yves.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, pp v54-v58, issn 0931-0509, SUP5Article

Aristolochic acid : the common culprit of Chinese herbs nephropathy and Balkan endemic nephropathyDE JONGE, Hylke; VANRENTERGHEM, Yves.Nephrology, dialysis, transplantation (Print). 2008, Vol 23, Num 1, pp 39-41, issn 0931-0509, 3 p.Article

Overcoming toxicities: New regimensGRINYO, J. M.Transplantation proceedings. 2001, Vol 33, Num 3A, pp S4-S6, issn 0041-1345, SUPConference Paper

Post-transplant diabetes mellitus: the last 10 years with tacrolimusBÄCKMAN, Lars A.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, pp vi13-vi16, issn 0931-0509, SUP6Conference Paper

Monoclonal antibodies in renal transplantation: old and newKUYPERS, Dirk R. J; VANRENTERGHEM, Yves F. C.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, Num 2, pp 297-300, issn 0931-0509, 4 p.Article

Removal of the protein-bound solute P-cresol by convective transport: A randomized crossover studyBAMMENS, Bert; EVENEPOEL, Pieter; VERBEKE, Kristin et al.American journal of kidney diseases. 2004, Vol 44, Num 2, pp 278-285, issn 0272-6386, 8 p.Article

Renal fonction: defining long-term successPASCUAL, Julio; MARCEN, Roberto; ORTUNO, Joaquin et al.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, pp vi3-vi7, issn 0931-0509, SUP6Conference Paper

Graft function and other risk factors as predictors of cardiovascular disease outcomeFORSYTHE, John L. R.Transplantation. 2001, Vol 72, Num 6, pp 16-19, issn 0041-1337, SUPConference Paper

Hyperlipidemia and cardiovascular disease after organ transplantationMASSY, Ziad A.Transplantation. 2001, Vol 72, Num 6, pp 13-15, issn 0041-1337, SUPConference Paper

Mechanisms and consequences of arterial hypertension after renal transplantationKOOMANS, Hein A; LIGTENBERG, Gerry.Transplantation. 2001, Vol 72, Num 6, pp 9-12, issn 0041-1337, SUPConference Paper

Strategies to minimize immunological and nonimmunological risk factors in the renal transplant populationFIRST, M. Roy.Transplantation. 2001, Vol 72, Num 6, pp 20-24, issn 0041-1337, SUPConference Paper

Immunosuppression: Does One Regimen Fit All?SPRANGERS, Ben; KUYPERS, Dirk R; VANRENTERGHEM, Yves et al.Transplantation. 2011, Vol 92, Num 3, pp 251-261, issn 0041-1337, 11 p.Article

Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patientsBAMMENS, Bert; EVENEPOEL, Pieter; VERBEKE, Kristin et al.American journal of kidney diseases. 2005, Vol 46, Num 3, pp 512-519, issn 0272-6386, 8 p.Article

The economic implications of non-adherence after renal transplantationCLEEMPUT, Irina; KESTELOOT, Katrien; VANRENTERGHEM, Yves et al.PharmacoEconomics (Auckland). 2004, Vol 22, Num 18, pp 1217-1234, issn 1170-7690, 18 p.Article

Impairment of small intestinal protein assimilation in patients with end-stage renal disease: extending the malnutrition-inflammation-atherosclerosis conceptBAMMENS, Bert; EVENEPOEL, Pieter; VERBEKE, Kristin et al.The American journal of clinical nutrition. 2004, Vol 80, Num 6, pp 1536-1543, issn 0002-9165, 8 p.Article

Time to reach tacrolimus maximum blood concentration, mean residence time, and acute renal allograft rejection: An open-label, prospective, pharmacokinetic study in adult recipientsKUYPERS, Dirk R. J; VANRENTERGHEM, Yves.Clinical therapeutics. 2004, Vol 26, Num 11, pp 1834-1844, issn 0149-2918, 11 p.Article

Evidence for impaired assimilation of protein in chronic renal failureBAMMENS, Bert; VERBEKE, Kristin; VANRENTERGHEM, Yves et al.Kidney international. 2003, Vol 64, Num 6, pp 2196-2203, issn 0085-2538, 8 p.Article

Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptomsBAMMENS, Bert; EVENEPOEL, Pieter; VERBEKE, Kristin et al.Kidney international. 2003, Vol 64, Num 6, pp 2238-2243, issn 0085-2538, 6 p.Article

Epidemiology of cardiovascular disease after renal transplantationKASISKE, Bertram L.Transplantation. 2001, Vol 72, Num 6, pp S5-S8, issn 0041-1337, SUPConference Paper

  • Page / 5